the vision to heal

The potential to simulate natural healing


Noveome is advancing its ST266 platform biologic, a first-of-its-kind, multi-targeted secretome containing hundreds of biologically active proteins and other factors crucial to neuroprotection, the modulation of inflammation, cell recovery and healing. We believe this novel platform biologic holds significant clinical potential across a range of important underserved conditions in ophthalmology, neurology, dermatology—and beyond.

exciting science

Learn more about ST266 and its unique and powerful healing potential.

advancing pipeline

Explore our portfolio covering a range of important ophthalmic indications.

rewarding careers

Join a passionate, diverse team dedicated to making a positive difference in patients’ lives.

making news

March 8, 2021

Noveome Biotherapeutics, Inc. Makes New Appointment to Board of Directors

February 22, 2021

Noveome Biotherapeutics, Inc. To Present At The 9th Annual Virtual…

February 1, 2021

Noveome Biotherapeutics, Inc. and Walter Reed Army Institute of Research…